Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2008 1
2009 2
2011 4
2012 2
2013 2
2015 2
2016 4
2017 8
2018 6
2019 14
2020 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Singapore Chapter of Rheumatologists consensus statement on the eligibility for government subsidy of biologic disease modifying anti-rheumatic agents for the treatment of psoriatic arthritis.
Lahiri M, Teng GG, Cheung PP, Suresh E, Chia FL, Lui NL, Koh DR, Koh WH, Leong KP, Lim AYN, Ng SC, Thumboo J, Lau TC, Leong KH. Lahiri M, et al. Among authors: lui nl. Int J Rheum Dis. 2017 Oct;20(10):1527-1540. doi: 10.1111/1756-185X.12685. Epub 2015 Sep 10. Int J Rheum Dis. 2017. PMID: 26353916 Review.
Consensus development on eligibility of government subsidisation of biologic disease modifying anti-rheumatic agents for treatment of ankylosing spondylitis: The Singapore experience.
Cheung PP, Lahiri M, Teng GG, Lui NL, Chia FL, Koh DR, Koh WH, Ng SC, Suresh E, Leong KP, Lim AYN, Thumboo J, Lau TC, Leong KH. Cheung PP, et al. Among authors: lui nl. Int J Rheum Dis. 2017 Oct;20(10):1517-1526. doi: 10.1111/1756-185X.12707. Epub 2015 Jul 14. Int J Rheum Dis. 2017. PMID: 26177789 Review.
Update on recommendations for eligibility of government subsidization of biologic disease-modifying antirheumatic drugs for the treatment of axial spondyloarthritis in Singapore.
Phang KF, Lahiri M, Fong WWS, Leong KH, Leung YY, Lim AYN, Lui NL, Manghani M, Tan TC, Santosa A, Sriranganathan MK, Suresh E, Teng GG, Cheung PP. Phang KF, et al. Among authors: lui nl. Int J Rheum Dis. 2020 Feb;23(2):165-173. doi: 10.1111/1756-185X.13744. Epub 2019 Nov 24. Int J Rheum Dis. 2020. PMID: 31762225 Review.
Singapore Chapter of Rheumatologists updated consensus statement on the eligibility for government subsidization of biologic and targeted-synthetic therapy for the treatment of rheumatoid arthritis.
Leong JWY, Cheung PP, Dissanayake S, Fong WWS, Leong KH, Leung YY, Lim AYN, Lui NL, Manghani M, Santosa A, Sriranganathan MK, Suresh E, Tan TC, Teng GG, Lahiri M. Leong JWY, et al. Among authors: lui nl. Int J Rheum Dis. 2020 Feb;23(2):140-152. doi: 10.1111/1756-185X.13762. Epub 2019 Dec 19. Int J Rheum Dis. 2020. PMID: 31859424 Review.
Singapore chapter of rheumatologists' updated consensus statement on the eligibility for government subsidization of biologic and targeted therapy for the treatment of psoriatic arthritis.
Chua CKT, Teng GG, Cheung PP, Fong WWS, Leong KH, Leung YY, Lim AYN, Lui NL, Manghani M, Santosa A, Sriranganathan MK, Suresh E, Tan TC, Lahiri M. Chua CKT, et al. Among authors: lui nl. Int J Rheum Dis. 2020 Feb;23(2):153-164. doi: 10.1111/1756-185X.13754. Epub 2019 Nov 24. Int J Rheum Dis. 2020. PMID: 31762214 Review.
Cardiomyopathy in ankylosing spondylitis.
Lui NL, Thumboo J, Inman R. Lui NL, et al. Arthritis Care Res (Hoboken). 2011 Apr;63(4):564-9. doi: 10.1002/acr.20333. Arthritis Care Res (Hoboken). 2011. PMID: 20740605 Free article. No abstract available.
An under-recognized cause of polyarthritis: leprosy.
Ker KJ, Pan JY, Lui NL, Tey HL. Ker KJ, et al. Among authors: lui nl. Ann Acad Med Singap. 2013 Jul;42(7):366-7. Ann Acad Med Singap. 2013. PMID: 23949270 Free article. No abstract available.
39 results